Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Folate-modified liposomes mediate the co-delivery of cisplatin with miR-219a-5p for the targeted treatment of cisplatin-resistant lung cancer

Fig. 3

Fluorescence imaging of cellular uptake of nanomedicine and expression levels of miR-219a-5p. (a) Uptake behavior of Lipo@DDP@miR-219a-5p-FA in A549 and BEAS-2B cells. Blue: nuclei of cells stained with DAPI; red: miR-219a-5p labeled with Cy5.5; (b, c) Fluorescence intensity (b) and corresponding expression levels (c) of miR-219a-5p in A549 cells after co-culturing with different nanoparticles; *p < 0.05

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us